Mednax is trading down 5.5% at $31.00 in pre-market on November 5, with the reason for the decline unconfirmed. - Shares closed at $32.80 on November 4. - No company-specific announcement explaining the decline was identified in available reports; the recent Q3 earnings release was on October 29. - Healthcare was up 1.55% pre-market, so sector gains do not explain the decline. No clear catalyst or volume details were available.